Ares-genetics.com Website Review

Microbial infections and antibiotic resistance can affect anybody, amounting to more than 15 Mio annual cases globally. Microbial infections and antibiotic resistance can affect anybody, amounting to more than 15 Mio annual cases globally. At Ares Genetics, we are working towards revolutionizing infectious disease diagnostics and thera*eutics by artificial intelligence based At Ares Genetics, we are working towards revolutionizing infectious disease diagnostics and thera*eutics by artificial intelligence based Conquering emerging antibiotic resistance, one of the biggest 21st century health threats and improving outcomes for patients with severe Revolutionizing infectious disease diagnostics and thera*eutics by translating success stories from next-generation diagnostics and Dr. Andreas E. Posch, Managing Director and CEO, joined from Siemens, where he developed Ares Genetics’ technology core and was responsible for Bioinformatics R&D at Siemens Healthcare as well as Software Sensors & An*lytics with Siemens Corporate Technology. Dr. Achim Plum, Managing Director, has more than 18 years of management experience in the diagnostics industry with a focus on innovative molecular diagnostics, biomarker development, and personalized medicine. Dr. Stephan Beisken, Head of Bioinformatics & An*lytics, joined from Discuva Limited, an antibiotic drug discovery company, where he was Since its incorporation in March 2017, ARES has established an international team of highly committed business and technology experts with proven innovation & commercialization track-record. ‍ Together, and supported by our global partner network, we are working towards revolutionizing infectious disease diagnostics and ARESDB builds on the GEnetic Antibiotic Resistance and Susceptibility Database (GEAR) and as*ociated as*ets that the Curetis Group acquired Since its incorporation in March 2017, Ares Genetics has continuously expanded ARESdb with various development partners from academia and